Cyclic adenosine meglumine injection and preparation method thereof

A technology of meglumine cyclic adenosine monophosphate and cyclic adenosine monophosphate, which is applied in the field of medicine, can solve problems such as the inability to guarantee the level of sterility assurance, and achieve the effects of ensuring the level of sterility assurance, low production cost, and strong safety
CN102283804AInactive Publication Date: 2011-12-21SHANDONG FANGMING PHARMACEUTICAL CO LTD
3 Cites 11 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SHANDONG FANGMING PHARMACEUTICAL CO LTD
Publication Date
2011-12-21
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention relates to an adenosine monophosphate meglumine injection and a preparation method thereof. The preparation process is to take an appropriate amount of water for injection, add sodium chloride, cyclic adenosine monophosphate, and meglumine, stir to dissolve completely, add 0.05-0.2% (W / V) activated carbon for needles by volume, and stir for 15-30 minutes. Filter to remove carbon, add water for injection to nearly full amount, use phosphate buffer to adjust the pH value to between 6.0 and 6.5, add water for injection to the full amount, and check that the semi-finished product is qualified, filter, potting (full nitrogen gas in the whole process), and extinguish Bacteria, light inspection, packaging. The method has the advantages of selecting appropriate solvents and additives, improving the solubility and stability of meglumine cyclic adenosine monophosphate, and adopting a terminal sterilization preparation method to effectively ensure the sterility assurance level of the drug. The invention has the characteristics of formula composition, simple process, low production cost, strong drug stability and safety, and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The invention relates to the technical field of medicine, and relates to a protein kinase activator meglumine cyclophosphate injection and a preparation method thereof. Background technique:

[0002] Meglumine Cyclic Adenosine Monophosphate is a protein kinase activator, a derivative of nucleotides, and an important regulatory substance in cells. Play hormone regulation physiological function and substance metabolism in the cell, can change the function of the cell membrane, promote the calcium ion in the reticulum sarcoplasm to enter the muscle fiber, thereby enhancing myocardial contraction, increasing coronary artery flow, protecting ischemic myocardium, and relaxing peripheral blood vessels , reducing myocardial oxygen consumption, is an effective drug for the treatment of heart failure, myocarditis, sick sinus syndrome, coronary heart disease and cardiomyopathy.

[0003] Since cyclic adenosine monophosphate is slightly soluble in water, meglumin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More